ILSI-Biomed Israel

Start-up Weekly: MGVS – a Israeli Cell / Gene Therapy Company

MGVS is a promising Israeli company, whose leading product has passed Phase I/II trial in December 2009 and could be used to treat critical limb ischemia. PLUS they're currently recruiting! Name: MGVS Ltd. CEO: Guy Yachin Sector: Biotechnology Suc-Sector: Cell therapy Medical Field: Cardiovascular Est.: 2000 Stage: Phase I/IIa Clinical trials Vision: To become the leader in advanced cell therapy based solutions for cardiovascular patients Employees: 21 and currentl...

Management ATUDA in the Biomedical Industry

A 100 Million NIS Prosecution because of a Failed Anti-Hair-Loss Product

As reported in Calcalist, the company 'Taam Teva-Altman' is being sued for allegedly advertising a certain mixture of vitamins as a baldness-stopper, for a sum of 100 million NIS Nobody likes pseudoscience, least of all those of us in the drugs market, who have to compete against homeopathic medicines. Those remedies, while completely useless, are vastly superior to conventional medicines on one front: they do not have to be confirmed by the FDA and similar authorities. Pretty much any ch...

A New Competition by MATIMOP, ILSI and the Office of the Chief Scientist

A new competition by MATIMOP, ILSI and the Office of the Chief Scientist, may pave the way for Israeli companies to the Bio International Convention in Chicago Wherever there is competition, people strive for improvement. That's the basis of capitalism, and the reason why companies in the West are usually more efficient than their subsidized and nationalized counterparts in the east, or in the ancient Soviet Union. The free market constitutes a competition all by itself, but why not add s...

Nanodrop Vs. Regular Spectrophotometer ?

A low-budget Youtube commercial for a Nanodrop spectrophotometer gives back its money worth - and much more Kindly watch the below video. It opens up slow, and it goes on even slower, but... well, it's only three minutes!     So what do we have here? Two nerdy looking scientists, having a painfully-mock argument about the virtues of the Nanodrop spectrophotometer as opposed to using the old fashioned spectrophotometer. Let me stress that I'm all for the Nanodrop device, as it tru...

Asthma Relief Inhalers Might Make Asthma Worse?

A new study at the University of Leicester is probing why asthma relief inhalers might actually make asthma worse - and what can be done about it Ever since the industrial revolution, asthma has become one of the most common medical conditions in the world, with an estimated 300 million people suffering from the condition worldwide. Being an asthmatic myself, I know that currently there is no cure for asthma, although there are 'relievers' – usually inhalers that relieve asthma symptoms by re...

Abstract Submissions Opening for ILSI-BioMed 2010

Abstract Submissions Opening for ILSI-BioMed 2010, up until March 10, 2010. If you know anything at all about the Biomed industry in Israel, then you're probably familiar with the ILSI-BioMed conference, which is held almost every year in the last decade. Last year's event drew 6,000 industry players, engineers and scientists, with 800 participants from 35 countries and in excess of 2,500 one-on-one meetings, and there's no reason for those numbers to go down this year. Why am I mentioning...

Innovative Uses for Old Devices: EEG to Decipher Artwork's Value

Acclair is a company and an ongoing research project utilizing an EEG device to figure out artwork's value and users' safety clearance. If there's one thing I hate it is being locked down to a single path, and being unable to switch lanes. Some of the most successful companies in the market made use of everyday technology to innovate: Facebook, Google and of course Apple. In the field of bio-med, however, I sometimes feel we're being somewhat narrow minded when it comes to the incredible device...

Innovative Uses for Old Devices: EEG to Decipher Artwork’s Value

Acclair is a company and an ongoing research project utilizing an EEG device to figure out artwork's value and users' safety clearance. If there's one thing I hate it is being locked down to a single path, and being unable to switch lanes. Some of the most successful companies in the market made use of everyday technology to innovate: Facebook, Google and of course Apple. In the field of bio-med, however, I sometimes feel we're being somewhat narrow minded when it comes to the incredible devi...

Safety Net for Fall-Prone Elderly Proves its Worth in Israel

A recent report from ICT Results reveals interesting information about a safety net for fall-prone elderly, with trials being conducted at three different sites: the Netherlands, Germany and Israel. Falls are the main cause of injuries among elderly people, but until now doctors have had few ways of effectively monitoring and counteracting mobility problems among patients. I think that any of us who've seen an elderly person in the weeks and months following a hip fracture, realize just how...